Common Stock, Shares, Outstanding of Oruka Therapeutics, Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Oruka Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Oruka Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 48,722,309, a 30% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Oruka Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 48,722,309 +11,281,799 +30% 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q3 2025 48,384,150 +13,385,600 +38% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 37,450,745 +22,943,602 +158% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 37,440,510 +22,939,367 +158% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 37,440,510 +22,939,367 +158% 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q3 2024 34,998,550 +20,588,407 +143% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 14,507,143 +97,000 +0.67% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 14,501,143 +91,000 +0.63% 31 Mar 2024 10-Q 25 Apr 2024 2024 Q1
Q4 2023 14,501,143 +91,000 +0.63% 31 Dec 2023 10-Q 01 Aug 2024 2024 Q2
Q3 2023 14,410,143 0 0% 30 Sep 2023 10-Q 18 Oct 2023 2023 Q3
Q2 2023 14,410,143 0 0% 30 Jun 2023 10-Q 21 Jul 2023 2023 Q1
Q1 2023 14,410,143 0 0% 31 Mar 2023 10-Q 24 Apr 2023 2023 Q1
Q4 2022 14,410,143 0 0% 31 Dec 2022 10-K 01 Feb 2024 2023 FY
Q3 2022 14,410,143 0 0% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 14,410,143 0 0% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 14,410,143 0 0% 31 Mar 2022 10-Q 02 May 2022 2022 Q1
Q4 2021 14,410,143 +4,861,993 +51% 31 Dec 2021 10-K 24 Feb 2023 2022 FY
Q3 2021 14,410,143 +5,124,519 +55% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 14,410,143 +12,142,573 +535% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 14,410,143 +12,816,073 +804% 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 9,548,150 +7,954,080 +499% 31 Dec 2020 10-K 14 Mar 2022 2021 FY
Q3 2020 9,285,624 +7,691,554 +483% 30 Sep 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 2,267,570 +812,014 +56% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 1,594,070 +495,257 +45% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 1,594,070 +820,512 +106% 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q3 2019 1,594,070 -12,329,755 -89% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 1,455,556 -12,468,269 -90% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 1,098,813 -12,815,507 -92% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 773,558 -11,001,504 -93% 31 Dec 2018 10-K 18 Feb 2020 2019 FY
Q3 2018 13,923,825 +2,173,081 +18% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 13,923,825 +3,807,239 +38% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 13,914,320 +4,741,452 +52% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 11,775,062 +2,692,696 +30% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q3 2017 11,750,744 +2,670,041 +29% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 10,116,586 +1,050,238 +12% 30 Jun 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 9,172,868 +116,221 +1.3% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 9,082,366 +31,149 +0.34% 31 Dec 2016 10-K 22 Mar 2018 2017 FY
Q3 2016 9,080,703 +30,914 +0.34% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 9,066,348 -54,153,642 -86% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 9,056,647 -12,141,764 -57% 31 Mar 2016 10-Q 11 May 2016 2016 Q1
Q4 2015 9,051,217 +6,029,719 +200% 31 Dec 2015 10-K 21 Mar 2017 2016 FY
Q3 2015 9,049,789 -12,090,697 -57% 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 63,219,990 +42,209,175 +201% 30 Jun 2015 10-Q 11 Aug 2015 2015 Q2
Q1 2015 21,198,411 +196,721 +0.94% 31 Mar 2015 10-Q 12 May 2015 2015 Q1
Q4 2014 3,021,498 -12,664,064 -81% 31 Dec 2014 10-K 17 Mar 2016 2015 FY
Q3 2014 21,140,486 +7,945,124 +60% 30 Sep 2014 10-Q 12 Nov 2014 2014 Q3
Q2 2014 21,010,815 +10,914,653 +108% 30 Jun 2014 10-Q 13 Aug 2014 2014 Q2
Q1 2014 21,001,690 +17,816,128 +559% 31 Mar 2014 10-Q 13 May 2014 2014 Q1
Q4 2013 15,685,562 +13,025,247 +490% 31 Dec 2013 10-K 19 Mar 2015 2014 FY
Q3 2013 13,195,362 -1,424,236 -9.7% 30 Sep 2013 10-Q 13 Nov 2013 2013 Q3
Q2 2013 10,096,162 -2,086,837 -17% 30 Jun 2013 10-Q 13 Aug 2013 2013 Q2
Q1 2013 3,185,562 -8,997,437 -74% 31 Mar 2013 10-Q 13 May 2013 2013 Q1
Q4 2012 2,660,315 +629,815 +31% 31 Dec 2012 10-K 20 Mar 2014 2013 FY
Q3 2012 14,619,598 +4,103,265 +39% 30 Sep 2012 10-Q 13 Nov 2012 2012 Q3
Q2 2012 12,182,999 +1,667,292 +16% 30 Jun 2012 10-Q 13 Aug 2012 2012 Q2
Q1 2012 12,182,999 31 Mar 2012 10-Q 14 May 2012 2012 Q1
Q4 2011 2,030,500 -6,804,035 -77% 31 Dec 2011 10-K 21 Mar 2013 2012 FY
Q3 2011 10,516,333 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 10,515,707 30 Jun 2011 10-Q 15 Aug 2011 2011 Q2
Q4 2010 8,834,535 31 Dec 2010 10-K 27 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.